Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002012383-25-000418·ADC Therapeutics SA
Schedule 13G ownership disclosure
ADC THERAPEUTICS SA
Common Stock · CUSIP: H0036K147
Event date: 2024-12-31
- Filing-level shares
- 5,011,857.00
- Percent of class
- 5.2%
- BlackRock, Inc.
Shares: 5,011,857.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-000418
- Form type
- SCHEDULE 13G
- Filer
- ADC Therapeutics SA
- CIK
- CIK 1771910
- Filed
- Feb 03, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership